Product image of Ipratropium Bromide Eg (Ipratropium Bromide Anhydrous) supplied by GNH India

Ipratropium Bromide Eg

Active Ingredient:
Ipratropium Bromide Anhydrous
Origin:
EU

Ipratropium Bromide Eg (Ipratropium Bromide Anhydrous)

Ipratropium Bromide, the active ingredient in Ipratropium Bromide Eg, is an anticholinergic (muscarinic antagonist) presented as a nasal spray for nasal use. It relieves nasal congestion associated with allergic rhinitis, the common cold, and vasomotor rhinitis.

GNH India supplies Ipratropium Bromide Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for import and distribution. Its global network ensures reliable delivery timelines and compliance with local pharmacopeial requirements.

Manufacturer / TM Owner

Eg Labo Laboratoires Eurogenerics

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ipratropium Bromide is a nasal anticholinergic indicated for the relief of nasal congestion by blocking muscarinic receptors in the nasal mucosa, thereby decreasing secretions and vasodilation.
  • Allergic rhinitis: reduces nasal congestion, rhinorrhea and sneezing, improving breathing comfort in patients with seasonal or perennial allergies.
  • Common cold: alleviates nasal blockage and excess secretions, helping patients experience easier airflow during viral upper respiratory infections.
  • Vasomotor rhinitis: improves nasal airflow and decreases watery discharge in non‑allergic, stimulus‑induced nasal congestion.

How It Works

  • Ipratropium Bromide is a quaternary ammonium anticholinergic that competitively inhibits acetylcholine at muscarinic (M1 and M3) receptors located on the nasal epithelium and submucosal glands. By preventing receptor activation, it reduces glandular secretion and diminishes vasodilation of nasal blood vessels, leading to decreased mucus production and improved airway patency. The effect is localized to the nasal cavity because the compound is poorly absorbed systemically, minimizing systemic anticholinergic activity.

Side Effects

Ipratropium Bromide may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nasal irritation or burning
  • Dryness of nasal passages
  • Unpleasant taste
  • Sneezing

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis)
  • Nasal ulceration or epistaxis
  • Paradoxical bronchospasm

Precautions & Warnings

Use Ipratropium Bromide only as prescribed and observe the following precautions.

  • Indication: Use only for nasal congestion as directed.
  • Hypersensitivity: Discontinue if signs of allergic reaction appear.
  • Glaucoma: Use with caution in patients with narrow‑angle glaucoma.
  • Urinary retention: Avoid in patients with prostatic hypertrophy or urinary retention.
  • Pregnancy: Safety not established; weigh benefits and risks.
  • Store at room temperature: Keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Ipratropium Bromide can interact with other medications; monitor the following.

Major Interactions (Avoid)

  • Concurrent use with other anticholinergic nasal sprays may increase anticholinergic load and risk of dryness.
  • Use with MAO inhibitors is not recommended due to potential additive effects on autonomic tone.

Moderate Interactions (Monitor Closely)

  • Co‑administration with antihistamines may enhance nasal dryness.
  • Combined use with ophthalmic anticholinergics may increase systemic exposure.
  • Use with drugs that prolong QT interval should be monitored for cardiac effects.

Frequently Asked Questions

Ipratropium Bromide Eg is a nasal spray that provides relief from nasal congestion caused by allergic rhinitis, the common cold, and vasomotor (non‑allergic) rhinitis. It works by reducing mucus production and swelling in the nasal passages, helping patients breathe more easily.

The active ingredient, Ipratropium Bromide, blocks muscarinic (M1 and M3) receptors on the nasal mucosa. This inhibition prevents acetylcholine‑mediated secretion and vasodilation, leading to decreased nasal secretions and reduced swelling, which improves airflow through the nose.

The prescribed dose and frequency are determined by the treating healthcare professional based on the patient’s condition and response. Patients should follow the prescriber’s instructions and the product labeling without altering the regimen on their own.

Safety data for Ipratropium Bromide in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing it to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike topical decongestants that act on blood vessels, Ipratropium Bromide reduces secretions by blocking muscarinic receptors. This mechanism often results in fewer rebound congestion effects compared with oxymetazoline or phenylephrine, making it suitable for longer‑term use under medical supervision.

Store the nasal spray at room temperature, away from direct sunlight and moisture. Keep the container tightly closed when not in use and protect it from extreme temperatures to maintain product stability.

The spray is applied intranasally. The patient gently inserts the nozzle into each nostril and actuates the pump as directed, typically one or two sprays per nostril. The exact regimen should follow the prescribing clinician’s guidance.

Serious but rare risks include severe allergic reactions such as anaphylaxis, nasal ulceration or bleeding, and paradoxical bronchospasm. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or persistent nosebleeds.

Individuals with known hypersensitivity to Ipratropium Bromide or any component of the formulation should avoid its use. Caution is also advised for patients with narrow‑angle glaucoma, urinary retention, or those taking multiple anticholinergic medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ipratropium Bromide Anhydrous

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT